Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
225 Leser
Artikel bewerten:
(1)

Diabetic Macular Edema Market size worth $ 4.87 Billion, Globally, by 2028 at 2.86% CAGR: Verified Market Research

Therapeutic agents for pain relief in appropriate doses and the introduction of new drugs are a few of the factors fueling the growth of this market.

JERSEY CITY, N.J., Oct. 7, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Diabetic Macular Edema Market" By Product (Anti VEGF Therapies, Corticosteroid Therapies), By Product Form (Intravitreal Injections and Intravitreal Implants), By Distribution Channel (Retail Pharmacies and Hospital Pharmacies), and By Geography. According to Verified Market Research, the Global Diabetic Macular Edema Market size was valued at USD 2.92 Billion in 2020 and is projected to reach USD 4.87 Billion by 2028, growing at a CAGR of 2.86% from 2021 to 2028.

Verified_Market_Research_Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=183965

Browse in-depth TOC on "Diabetic Macular Edema Market"

202 - Pages

126 - Tables

37 - Figures

Global Diabetic Macular Edema Market Overview

Diabetic macular edema is caused by a variety of factors, which necessitates a thorough understanding of the disease's pathophysiology and molecular mechanisms. In recent years, pharmaceutical companies have targeted combinations of multiple medicines for the treatment of DME, aiming to target separate routes or different steps of the same process. Medication and laser surgery are two well-established treatments targeted at keeping the patient's vision and reducing future vision loss.

The growing prevalence of chronic conditions such as diabetes is driving the global Diabetic Macular Edema Market. Diabetic Macular Edema is a highly common indication, and innovative medications are being developed to treat it. Diabetic macular edema is caused by a variety of factors, which necessitates a thorough understanding of the disease's pathophysiology and molecular mechanisms. In recent years, pharmaceutical companies have targeted combinations of multiple medicines for the treatment of DME, aiming to target separate routes or different steps of the same process.

Key Developments in Diabetic Macular Edema Market

  • In May 2021, Faricimab (Roche), KSI 301 (Kodiak Sciences Inc.), and Beovu (Novartis) late-stage products have shown promising results in diabetic macular edema and are expected to improve the dosing interval.

The major players in the market are Pfizer Inc, Allergan PLC, Novartis AG, Clearside Biomedical Inc, Ariam Pharmaceuticals, Valeant Pharmaceuticals, Regenron PLC, Bayer AG, pSivida Corporation, Alimera Sciences Inc.

Verified Market Research has segmented the Global Diabetic Macular Edema Market On the basis of Product, Product Form, Distribution Channel, and Geography.

  • Diabetic Macular Edema Market, By Product
    • Anti VEGF Therapies
    • Corticosteroid Therapies
    • Other Off-label Drugs
  • Diabetic Macular Edema Market, By Product Form
    • Intravitreal Injections
    • Intravitreal Implants
  • Diabetic Macular Edema Market, By Distribution Channel
    • Retail Pharmacies
    • Hospital Pharmacies
  • Diabetic Macular Edema Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Eye Health Supplements Market By Ingredient (Lutein and Zeaxanthin, Antioxidants, Omega-3 fatty acids, Coenzyme Q10), By Indication (Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome), By Form (Tablet, Capsule, Drops), By Geography, Forecast, 2020-2027

Autoinjectors Market By Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), By Application (Anaphylaxis, Multiple Sclerosis, Diabetes), By End-User (Home Care Settings, Hospitals And Clinics), By Geography, Forecast, 2020-2027

Human Insulin Market By Application (Type I Diabetes and Type II Diabetes), By Delivery Device (Syringes, Pens, Pen Needles), By Brand (HI Analogs & Biosimilars and HI Biologics), By Type (Insulin Analogs & Biosimilars and HI Biologics), By Product Type (HI Drugs and HI Delivery Devices), By Geography, Forecast, 2020-2027

Autoimmune Disease Therapeutics Market By Drug (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Anti-inflammatory, Interferons, Antihyperglycemics), By Disease (Multiple Sclerosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Type 1 Diabetes), By Geography, Forecast, 2020-2027

Top 10 antidiabetics pharma companies stopping the silent killer: Sugar rush

Visualize Diabetic Macular Edema Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

© 2021 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.